Genomic Health (GHDX) Tops Q1 EPS by 5c

Genomic Health (NASDAQ: GHDX) reported Q1 EPS of ($0.02), $0.05 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $83.98 million versus the consensus estimate of $86.19 million.

For earnings history and earnings-related data on Genomic Health (GHDX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c